This is to inform that due to some circumstances beyond the organizer control, “International Conference on Medicinal Chemistry, Computer Aided Drug Design and Delivery” (MCADD 2023) Hybrid event during September 14-16, 2023 at Valencia, Spain has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at medicinal-chemistry@magnusconference.com or call + 1 (702) 988 2320.
The structural–activity relationship (SAR) describes the link between a molecule's chemical structure and its biological activity. The determination of the chemical group responsible for triggering a target biological action in the organism is possible via SAR analysis. This allows for the change of a bioactive compound's action or potency (usually a medication) by altering its chemical structure. Medicinal chemists employ chemical synthesis techniques to introduce new chemical groups into medicinal compounds and then test their biological effects. The Structure-Activity Relationship (SAR) method is used to discover correlations between a compound's chemical structure (or structural-related attributes) and its biological activity (or target property). As such, it is the idea of connecting chemical structure to a chemical characteristic (e.g., water solubility) or biological activity (e.g., toxicity) (e.g., fish acute mortality). (Q)SARs are a term that refers to both qualitative and quantitative SARs. Non-continuous data (e.g., yes/no data) yields qualitative relationships, whereas continuous data yields quantitative correlations (e.g., toxic potency data).
Title : A qsar survey on tyrosine kinase inhibitors
Atefeh Hajiagha Bozorgi, Faculty of pharmacy, Iran (Islamic Republic of)
Title : Abbott diagnostics: COVID-19 inactivation, nucleocapsid antigen automated immunoassay development, and variant testing for automated and lateral flow assays binaxnow™ and panbio™
Philip M Hemken, Abbott Laboratories, United States
Title : Synthesis, antibacterial activity of 3-amino 5-methoxyl-2-methyl quinazolin-4(3H)-one an amino-6-methoxyl-2-methyl of 4H–benzo[d] [1,3]–oxazine–4–one
Osarumwense Peter Osarodion, Ondo State University of Sciences and Technology, Nigeria
Title : Tackling mycobacterium tuberculosis resistance with tailored isatin-pyrimidine hybrids enoyl acyl carrier protein reductase (Inha)
Amgad Albohy, The British University in Egypt (BUE), Egypt
Title : Transition metal complexes/Organometallic compounfs as anticancer drugs
Prakash kinthda, Nims university,jaipur,rajasthan, India
Title : New n-ribosides and n-mannosides of rhodanine derivatives with anticancer activity on leukaemia cell line: Design, synthesis, dft and molecular modelling studies
Ahmed, Kafrelsheikh University, Egypt